ANEBULO PHARMACEUTICALS, INC. Cash
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Cash of $11.25 million as of 2023-06-30, per its 10-K filed 2023-09-22.
Discontinued › Balance Sheet › Assets, Current
us-gaap:Cash · last filed 2023-09-22
- 2023-06-30: Cash $11.25M.
- 2023-03-31: Cash $14.16M.
- 2022-12-31: Cash $16.36M.
- 2022-09-30: Cash $19.21M.
| Period end | Cash |
|---|---|
| 2023-06-30 | $11.25M 10-K · filed 2023-09-22 |
| 2023-03-31 | $14.16M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $16.36M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $19.21M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $14.55M 10-K · filed 2023-09-22 |
| 2022-03-31 | $16.55M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $18.01M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $19.21M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $19.99M 10-K · filed 2022-09-09 |
| 2020-06-30 | $3.02M 10-K · filed 2021-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |